Regency Centers (REG): Director received 479 shares; owns 111,397

C. Ronald Blankenship, a director of Regency Centers Corporation (REG), received 479 shares of common stock as payment of director fees under Regency's Omnibus Incentive Plan.

Rhea-AI Filing Summary

C. Ronald Blankenship, a director of Regency Centers Corporation (REG), received 479 shares of common stock as payment of director fees under Regency's Omnibus Incentive Plan. The transaction is reported in Table I as a non-derivative acquisition (code A) and increases his direct beneficial ownership to 111,397 shares. The Form 4 indicates no derivative securities were acquired or disposed of and lists the reporting relationship as Director. The filing also shows the Form was submitted by one reporting person and executed by Michael R. Herman as attorney-in-fact.

This report documents a stock-based compensation event for a director and provides the post-transaction share total; no other classes of securities or material terms beyond the issuance for director fees are disclosed in the filing.

Insights

Financial Analyst

TL;DR: Director C. Ronald Blankenship received 479 shares as director compensation, raising his direct holdings to 111,397 shares.

The Form 4 records a non-derivative acquisition (code A) of 479 common shares issued pursuant to the companys Omnibus Incentive Plan and reports the holders status as a director. The filing contains no derivative transactions, no disposals, and no additional compensation details such as per-share valuation. For investors, this is a routine equity issuance for director fees rather than a market purchase or a material change in ownership stake.

Corporate Governance Expert

TL;DR: Transaction reflects director fee settlement in stock under the Omnibus Incentive Plan; filing is informational and routine.

The disclosure clearly states the shares were issued as director fees under the Omnibus Incentive Plan and shows the reporting relationship as Director. The Form 4 was filed by one reporting person and signed by an attorney-in-fact. There are no indications of transactions outside routine compensation; the report does not disclose any changes in control, derivative instruments, or unusual arrangements.

Insider Trade Summary

Grant/Award: 479 shares

Grant/Award 1 txn

Insider BLANKENSHIP C RONALD

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	479	$0.00	$0.00

Holdings After Transaction: Common Stock — 111,397 shares (Direct)

Footnotes (1)

1. F1. Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did C. Ronald Blankenship report on Form 4 for Regency Centers (REG)?

The Form 4 reports the non-derivative acquisition of 479 shares of Regency Centers common stock as payment of director fees.

How many REG shares does C. Ronald Blankenship beneficially own after the reported transaction?

Following the reported transaction, he beneficially owns 111,397 shares directly.

Under what plan were the 479 REG shares issued?

The shares were issued pursuant to Regencys Omnibus Incentive Plan as director compensation, per the filings explanation of responses.

Was any derivative security reported in this Form 4 for REG?

No. Table II in the filing contains no entries; the reported transaction appears in Table I as a non-derivative security acquisition.

What is the reporting relationship of the person who filed the Form 4 for REG?

The filing lists the reporting person, C. Ronald Blankenship, as a Director of Regency Centers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/08/2025 - 02:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BLANKENSHIP C RONALD

(Last) (First) (Middle)

5004 GREEN TREE

(Street)

HOUSTON TX 77056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REGENCY CENTERS CORP [ REG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/08/2025		A		479	A	(1)	111,397	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan.

	/s/ Michael R. Herman, Attorney-in-Fact for C. Ronald Blankenship	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.